Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15995833rdf:typepubmed:Citationlld:pubmed
pubmed-article:15995833lifeskim:mentionsumls-concept:C0015576lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C0337810lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1421224lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C0206246lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1843571lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1850419lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1970036lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1550594lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1548760lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C1547300lld:lifeskim
pubmed-article:15995833lifeskim:mentionsumls-concept:C0580822lld:lifeskim
pubmed-article:15995833pubmed:issue2lld:pubmed
pubmed-article:15995833pubmed:dateCreated2005-7-4lld:pubmed
pubmed-article:15995833pubmed:abstractTextArg47 is a rare transthyretin-related (TTR) amyloidosis variant that is characterised by polyneuropathy and autonomic failure. We describe an Italian family with this mutation whose members (two women and their father) showed a rapid progression of the peripheral nervous system involvement and died within 5 years of clinical onset. Patients with Arg47 or other aggressive TTR amyloidoses should be considered high priority patients for orthotopic liver transplantation.lld:pubmed
pubmed-article:15995833pubmed:languageenglld:pubmed
pubmed-article:15995833pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15995833pubmed:citationSubsetIMlld:pubmed
pubmed-article:15995833pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15995833pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15995833pubmed:statusMEDLINElld:pubmed
pubmed-article:15995833pubmed:monthJunlld:pubmed
pubmed-article:15995833pubmed:issn1590-1874lld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:TassinariC...lld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:SalviFFlld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:FerliniAAlld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:PlasmatiRRlld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:MascalchiMMlld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:GraziG LGLlld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:JovineEElld:pubmed
pubmed-article:15995833pubmed:authorpubmed-author:PastorelliFFlld:pubmed
pubmed-article:15995833pubmed:issnTypePrintlld:pubmed
pubmed-article:15995833pubmed:volume26lld:pubmed
pubmed-article:15995833pubmed:ownerNLMlld:pubmed
pubmed-article:15995833pubmed:authorsCompleteYlld:pubmed
pubmed-article:15995833pubmed:pagination140-2lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:meshHeadingpubmed-meshheading:15995833...lld:pubmed
pubmed-article:15995833pubmed:year2005lld:pubmed
pubmed-article:15995833pubmed:articleTitleEarly onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation.lld:pubmed
pubmed-article:15995833pubmed:affiliationDepartment of Neurological Sciences, University of Bologna at Bellaria Hospital, Bologna, Italy. fabrizio.salvi@ausl.bo.itlld:pubmed
pubmed-article:15995833pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:7276entrezgene:pubmedpubmed-article:15995833lld:entrezgene
entrez-gene:24856entrezgene:pubmedpubmed-article:15995833lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15995833lld:entrezgene